Immediate Impact
20 from Science/Nature 58 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
2021 Standout
Works of Michael O. Montgomery being referenced
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States
2012
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael O. Montgomery | 433 | 164 | 122 | 434 | 253 | 9 | 806 | |
| Aurélie Guguin | 280 | 484 | 39 | 124 | 158 | 7 | 888 | |
| K Illingworth | 177 | 122 | 21 | 108 | 83 | 16 | 750 | |
| Kenneth O. Rothaus | 353 | 189 | 8 | 169 | 66 | 19 | 978 | |
| Claudia Specchia | 91 | 402 | 58 | 109 | 182 | 22 | 894 | |
| Sevim Barbasso Helmers | 67 | 171 | 24 | 145 | 685 | 17 | 865 | |
| Stuart M. Levine | 73 | 276 | 23 | 83 | 413 | 21 | 945 | |
| Jan Jernbeck | 466 | 65 | 34 | 99 | 22 | 22 | 709 | |
| Xiaoqiang Han | 100 | 210 | 171 | 50 | 75 | 23 | 926 | |
| Brian P. Lipsky | 130 | 212 | 14 | 118 | 44 | 10 | 832 | |
| Abraham Menahem Nahir | 240 | 93 | 66 | 41 | 51 | 17 | 785 |
All Works
Loading papers...